KOMPLEKSNYY PODKhOD K LEChENIYu MIGRENI


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Migraine represents a neurologic disease which is characterized by repetitive attacks of the severe headache and specific accompanying symptoms. In spite of the fact that migraine doesn't threaten life of patients, this disease leads to the reduction in the quality of life. As opposed to many other neurologic diseases, diagnosis of migraine does not require additional methods of examination (diagnostics is based on the analysis of the anamnesis, complaints and physical examination of patient). It is possible to select three main objectives in the treatment of migraine: prevention of attacks, their treatment and prevention. One of effective drugs for the relief of migraine attacks is combined preparation Nomigren containing 0,75 mg of ergotamine tartrate, 80 mg of caffeine, 200 mg of propyphenazone, 20 mg of mecloxamine citrate and 25 mg camilofine chloride. Active substances of Nomigren affect different links of migraine pathogenesis. Due to synergy effect of the active substances, the summary effect is reached against the background of use of smaller doses of different components that reduces probability of development of side effects.

Full Text

Restricted Access

References

  1. Rasmussen B.K, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991;44:1147-57.
  2. Рачин А.П., Осипова В.В., Юдельсон Я.Б. Мигрень: от правильной диагностики к адекватной терапии // Справочник поликлинического врача 2007. Т. 5. № 1. С. 51-56.
  3. Осипова В.В., Табеева Г.Р. Первичные головные боли. М., 2007. 60 с.
  4. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21(10):718-79.
  5. Diamond S. Migraine Headache. In: Diamond and Dalessio s The practicing physician s approach to headache, 6th ed. Saunders 1999:46-71.
  6. Амелин А.В., Игнатов Ю.Д., Скоромец А.А. Мигрень (патогенез, клиника, лечение). СПб., 2001. 199 с.
  7. Lipton R.B, Stewart W.F, Stone A.M, et al. Stratified care is step care stratages for migraine: The disability in strategies of care (DISC) study: a randomized trial. JAMA 2000;284:2599-605.
  8. Данилов А.Б., Коржавина В.Б. Современные подходы к лечению пациентов с мигренью // РМЖ 2011. Специальный выпуск: Болевой синдром. С. 16-19.
  9. Allais G, Castagnoli Gabellari I, De Lorenzo C, et al. Menstrual migraine: clinical and therapeutical aspects. Expert Rev Neurother 2007;7:1105-20.
  10. Азимова Ю.Э., Осипова В.В. Мигрень и эрготы: от истории к современности // Consilium medicum, Неврология 2011. № 1. С. 21-23.
  11. Григорова И.А., Лещенко О.К. Номигрен в структуре патогенетического лечения мигрени и мигренозного приступа // Буковинський Медичний Вісник 2005.№ 3. С. 17-22.
  12. Мищенко Т.С., Реминяк И.В. Современные подходы к диагностике и лечению мигрени. Номигрен в патогенетической терапии мигрени // Украинский вестник психоневрологии 2004. № 2. С. 46-54.
  13. Табеева Г.Р., Азимова Ю.Э. Профилактическое лечение мигрени. М., 2009. 84 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies